Back to Search Start Over

Epithelial cells derived exosomal miR-203a-3p facilitates stromal inflammation of type IIIA chronic prostatitis/chronic pelvic pain syndrome by targeting DUSP5 and increasing MCP-1 generation.

Authors :
Song G
Zhao F
Ni R
Deng B
Chen S
Hu R
Zheng J
Peng Y
Liu H
Luo Y
Zhou Z
Huang G
Shen W
Source :
Journal of nanobiotechnology [J Nanobiotechnology] 2024 May 10; Vol. 22 (1), pp. 236. Date of Electronic Publication: 2024 May 10.
Publication Year :
2024

Abstract

Increased proinflammatory cytokines and infiltration of inflammatory cells in the stroma are important pathological features of type IIIA chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS-A), and the interaction between stromal cells and other cells in the inflammatory microenvironment is closely related to the inflammatory process of CP/CPPS-A. However, the interaction between stromal and epithelial cells remains unclear. In this study, inflammatory prostate epithelial cells (PECs) released miR-203a-3p-rich exosomes and facilitated prostate stromal cells (PSCs) inflammation by upregulating MCP-1 expression. Mechanistically, DUSP5 was identified as a novel target gene of miR-203a-3p and regulated PSCs inflammation through the ERK1/2/MCP-1 signaling pathway. Meanwhile, the effect of exosomes derived from prostatic fluids of CP/CPPS-A patients was consistent with that of exosomes derived from inflammatory PECs. Importantly, we demonstrated that miR-203a-3p antagomirs-loaded exosomes derived from PECs targeted the prostate and alleviated prostatitis by inhibiting the DUSP5-ERK1/2 pathway. Collectively, our findings provide new insights into underlying the interaction between PECs and PSCs in CP/CPPS-A, providing a promising therapeutic strategy for CP/CPPS-A.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
1477-3155
Volume :
22
Issue :
1
Database :
MEDLINE
Journal :
Journal of nanobiotechnology
Publication Type :
Academic Journal
Accession number :
38724995
Full Text :
https://doi.org/10.1186/s12951-024-02513-5